A phase I study of pemetrexed in patients with relapsed or refractory acute leukemia.
Abdel-Karim I, Plunkett WK Jr, O'Brien S, Giles F, Thomas D, Faderl S, Ravandi F, Rios MB, Du M, Schneck KB, Chen VJ, Lin BK, Nicol SJ, Kantarjian HM.
Abdel-Karim I, et al.
Invest New Drugs. 2011 Apr;29(2):323-31. doi: 10.1007/s10637-009-9369-7. Epub 2010 Jan 21.
Invest New Drugs. 2011.
PMID: 20091088
Free PMC article.
Clinical Trial.